The Quantellect read.As of Nov 19, 2026, 6 active firms cover Argan Inc: 3 rate it Buy or better, 2 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets range widely, $273.00 to $785.00 (about 2.9x), a sign of real disagreement on valuation. The average target of $504.33 sits 66% above the current $303.70. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees revenue growth near 33% this year and 21% next, consensus EPS building from about $3.20 next quarter toward $16.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Neutral
Strong Buy00%
Buy350%
Neutral233%
Sell117%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$504.33
+66.1% upside
Average target across 6 active firms as of Nov 19, 2026 vs $303.70 current
Highest Target$785.00
Average Target$504.33
Lowest Target$273.00
Detailed analyst forecasts for AGX
Showing 1–5 of 5 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 3 of 6 active firms rate AGX a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AGX EPS & revenue forecast
EPS · NEXT QUARTER
$3.20
Range $2.83 – $3.82 · 5 analysts · -8% YoY
Next period, 5 analysts expect Argan Inc to earn $3.20 a share (range $2.83 – $3.82), versus $3.47 a year earlier. Full-year consensus is $13.27, growing to $16.11 the year after.
REVENUE · NEXT QUARTER
$367.3M
Range $340.0M – $406.0M · 5 analysts · +25% YoY
Revenue is expected to reach $367.3M (range $340.0M – $406.0M), +25.0% year-over-year. Full-year consensus is $1.4B, rising to $1.7B next year.
Top analysts covering Argan Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AGX.
#1
RB
Robert Brown
Lake Street
Buy
$600.00+97.6% to target
Coverage
—
+ Follow
#2
MF
Michael Fairbanks
JP Morgan
Buy
$785.00+158.5% to target
Coverage
—
+ Follow
#3
AW
Austin Wang
GLJ Research
Buy
$369.00+21.5% to target
Coverage
—
+ Follow
#4
KK
Kai Klose
Berenberg
Neutral
$79.00-74.0% to target
Coverage
—
+ Follow
#5
AM
Atidrip Modak
Goldman Sachs
Buy
$518.00+70.6% to target
Coverage
—
+ Follow
AGX stock forecast FAQ
What is AGX's average 12-month price target?+
The 6 active firms with a live target average $504.33 for Argan Inc over the next 12 months, ranging from a $785.00 high to a $273.00 low, as of Nov 19, 2026.
Is AGX stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 6 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 2 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AGX?+
The Street-high target is $785.00 (JP Morgan), and the Street-low is $273.00 (Piper Sandler). The average of all 6 active-firm targets is $504.33.
How many active Wall Street firms cover AGX?+
6 active firms have a recognized rating on Argan Inc as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AGX?+
Among analysts who currently cover AGX, Robert Brown of Lake Street has the strongest overall Quantellect track record. Their current call is Buy with a $600.00 target.
What is Argan Inc's projected EPS for next quarter?+
The consensus estimate is $3.20 per share (range $2.83 – $3.82) across 5 analysts. Full-year EPS is projected at $13.27, rising to $16.11 the following year.
How much revenue is Argan Inc expected to report next quarter?+
Consensus revenue is $367.3M (range $340.0M – $406.0M). Full-year revenue is projected at $1.4B, growing to $1.7B next year.
Have analysts been upgrading or downgrading AGX lately?+
As of Nov 19, 2026, 3 of 6 active firms rate AGX a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AGX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.